4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY, UT
Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Reports First Quarter 2026 Financial Results
Earnings Release
Co-Diagnostics, Inc. Complies with Nasdaq Listing Requirements
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Reverse Stock Split
Submission of Matters to a Vote of Security Holders
Reports Third Quarter 2025 Financial Results
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
S-8 POS